Project Profile

Dose-Finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects with Type 2 Diabetes Subtitle: A 26-Week, Multicentre, Double-Blind, Randomised, Controlled Dose-Finding Trial, Phase 2

Keyword Search